Holen Sie sich die Stockscreener-App
0.295
4.54%
0.0128
Schlusskurs vom Vortag:
$0.2822
Offen:
$0.2817
24-Stunden-Volumen:
739.02K
Relative Volume:
0.10
Marktkapitalisierung:
$46.84M
Einnahmen:
$49.09M
Nettoeinkommen (Verlust:
$-52.15M
KGV:
-0.4538
EPS:
-0.65
Netto-Cashflow:
$-45.93M
1W Leistung:
+7.19%
1M Leistung:
-2.32%
6M Leistung:
-80.72%
1J Leistung:
-80.72%
1-Tages-Spanne:
$0.2732
$0.30
1-Wochen-Bereich:
$0.2503
$0.30
52-Wochen-Spanne:
$0.1718
$2.04
Biodesix Inc Stock (BDSX) Company Profile
Firmenname
Biodesix Inc
Sektor
Branche
Telefon
303-417-0500
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Vergleichen Sie BDSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
0.2945 | 46.84M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
418.87 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
200.38 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
541.50 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.26 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
162.54 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-07-26 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-13 | Eingeleitet | TD Cowen | Buy |
| 2024-05-03 | Eingeleitet | Lake Street | Buy |
| 2021-11-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Eingeleitet | BTIG Research | Buy |
| 2020-11-23 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-23 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 127.0% in May - Defense World
Biodesix, Inc. (NASDAQ:BDSX) Stock Rockets 30% But Many Are Still Ignoring The Company - simplywall.st
Millennium Management LLC Buys 33,329 Shares of Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix (BDSX) Partners with APAPP to Enhance Lung Cancer Care - GuruFocus
Biodesix, Inc. Partners with Association of Pulmonary Advanced Practice Providers to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs - MarketScreener
Biodesix Partners with Association of Pulmonary Advanced Practic - GuruFocus
Biodesix partners with Association of Pulmonary APPs for lung cancer education - TipRanks
Public market insider buying at Freehold Royalties (FRU) - The Globe and Mail
Biodesix Partners with Association of Pulmonary Advanced - GlobeNewswire
Biodesix Partners with APAPP to Enhance Lung Cancer Education and Access to Diagnostic Tools - Nasdaq
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs - Yahoo
Jane Street Group LLC Acquires New Holdings in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Wall Street’s big rally stalls following some discouraging economic data - The Globe and Mail
Biodesix at 45th Annual William Blair Growth Stock Conference: Lung Health Focus - Investing.com Canada
Northern Trust Corp Grows Stake in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting - The Manila Times
Scotiabank Has Lowered Expectations for Biodesix (NASDAQ:BDSX) Stock Price - Defense World
Biodesix Announces New Data on the VeriStrat® Test to be Present - GuruFocus
Biodesix to Present New Data on Host Immune Classifier for NSCLC at 2025 ASCO Annual Meeting - Nasdaq
Game-Changing Cancer Test Triples Survival Rate: New Clinical Data Transforms Lung Cancer Treatment - Stock Titan
Independent Director of Biodesix Picks Up 15% More Stock - Yahoo Finance
Biodesix (BDSX) Target Price Reduced to $2 by Scotiabank | BDSX Stock News - GuruFocus
Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut By Stocktwits - Investing.com India
Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut - MSN
Scotiabank cuts Biodesix stock target to $2, maintains outlook By Investing.com - Investing.com Canada
Biodesix Approves Reverse Stock Split at Annual Meeting - TipRanks
Scotiabank cuts Biodesix stock target to $2, maintains outlook - Investing.com
Biodesix (BDSX) Sees Target Price Lowered by Scotiabank | BDSX S - GuruFocus
Biodesix (BDSX) Sees Target Price Lowered by Scotiabank | BDSX Stock News - GuruFocus
Biodesix price target lowered to $2 from $3 at Scotiabank - TipRanks
Biodesix to Participate in Upcoming Investor Conferences | BDSX Stock News - GuruFocus
Biodesix to Participate in Upcoming Investor Conferences - GlobeNewswire
Biodesix Executives Set for Major Investor Conferences: William Blair and Craig-Hallum Presentations Ahead - Stock Titan
What's Behind The Big Stock Moves? BDSX, APLM, RNAZ... - Nasdaq
Director’s Massive Stock Purchase Signals Confidence in Biodesix! - TipRanks
Biodesix, Inc. (NASDAQ:BDSX) Shares Bought by Cubist Systematic Strategies LLC - Defense World
Biodesix's (BDSX) "Market Perform" Rating Reaffirmed at William Blair - MarketBeat
Craig Hallum Cuts Biodesix (NASDAQ:BDSX) Price Target to $1.50 - Defense World
William Blair Has Bearish Estimate for Biodesix Q2 Earnings - Defense World
Biodesix revises 2025 revenue guidance to $80M–$85M amid sales force reconfiguration and primary care expansion - MSN
Susquehanna International Group LLP Grows Stock Holdings in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance
Biodesix, Inc. Earnings Call: Growth Amid Challenges - TipRanks
Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript - MSN
Analysts Just Slashed Their Biodesix, Inc. (NASDAQ:BDSX) EPS Numbers - simplywall.st
Biodesix Announces New Clinical and Economic Data for Its Nodify Lung® Tests At ISPOR and ATS - marketscreener.com
News Flash: 6 Analysts Think Biodesix, Inc. (NASDAQ:BDSX) Earnings Are Under Threat - Yahoo Finance
Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS | BDSX Stock News - GuruFocus
Biodesix, Inc. to Present New Data on Lung Cancer Diagnosis and Testing at ISPOR and ATS 2025 Conferences - Nasdaq
Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS - GlobeNewswire
New Clinical Data: Biodesix Lung Cancer Tests Could Prevent 60% of Unnecessary Invasive Procedures - Stock Titan
Finanzdaten der Biodesix Inc-Aktie (BDSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Biodesix Inc-Aktie (BDSX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SCHULER JACK W | Director |
May 19 '25 |
Buy |
0.34 |
723,239 |
246,624 |
20,918,174 |
| Vazquez Chris | Chief Accounting Officer |
May 12 '25 |
Sale |
0.36 |
112 |
40 |
18,113 |
| Vazquez Chris | Chief Accounting Officer |
May 13 '25 |
Sale |
0.35 |
112 |
40 |
18,001 |
| Pestano Gary Anthony | Chief Development Officer |
May 12 '25 |
Sale |
0.36 |
223 |
80 |
157,163 |
| Pestano Gary Anthony | Chief Development Officer |
May 13 '25 |
Sale |
0.35 |
222 |
78 |
156,941 |
| O'Kane Kieran | Chief Commercial Officer |
May 12 '25 |
Sale |
0.36 |
239 |
86 |
139,290 |
| O'Kane Kieran | Chief Commercial Officer |
May 13 '25 |
Sale |
0.35 |
238 |
84 |
139,052 |
| Hutton Scott | President & CEO |
May 12 '25 |
Sale |
0.36 |
1,888 |
679 |
722,271 |
| Hutton Scott | President & CEO |
May 13 '25 |
Sale |
0.35 |
1,887 |
666 |
720,384 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer |
May 12 '25 |
Sale |
0.36 |
496 |
178 |
249,121 |
0.56%
2.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):